Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06616311 · ClinicalTrials.gov registry record · NA
Efficacy of Radiofrequency Micro Needling for the Treatment of Melasma in Skin of Color.
A NA study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT06616311 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 10 participants.
The verdict
NCT06616311, a NA study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The objective of this study is to test the effectiveness of radiofrequency microneedling (RFMN) as a treatment for melasma. The Investigator hypothesize that RFMN will be an effective treatment for melasma in skin of color patients.
Interventions
- DEVICE Radiofrequency microneedling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-10-01 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06616311
The ClinicalTrials.gov registry entry for NCT06616311 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Radiofrequency microneedling is the first listed.
NCT06616311 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06616311 about?
NCT06616311 is a clinical study titled "Efficacy of Radiofrequency Micro Needling for the Treatment of Melasma in Skin of Color.". The objective of this study is to test the effectiveness of radiofrequency microneedling (RFMN) as a treatment for melasma. The Investigator hypothesize that RFMN will be an effective treatment for melasma in skin of color patients.
What is the current status of trial NCT06616311?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2024-10-01. Estimated completion is 2025-12-31.
What interventions are being tested in trial NCT06616311?
The interventions under investigation include: Radiofrequency microneedling (DEVICE).
Who is sponsoring clinical trial NCT06616311?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.